Ingevity Corp Files Routine 8-K
Ticker: NGVT · Form: 8-K · Filed: 2025-12-08T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, 8-k, regulation-fd
Related Tickers: INGV
TL;DR
INGEVITY CORP FILED A STANDARD 8-K ON DEC 8, 2025. NO MAJOR NEWS.
AI Summary
On December 8, 2025, Ingevity Corporation filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or transactional details beyond its routine reporting nature.
Why It Matters
This filing indicates Ingevity Corporation is meeting its regulatory reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine filing that does not disclose any new material information or significant events.
Key Players & Entities
- Ingevity Corporation (company) — Registrant
- 4920 O'Hear Avenue (location) — Principal executive offices address
- North Charleston (location) — City of principal executive offices
- 29405 (location) — Zip code of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to include Financial Statements and Exhibits, as indicated in the filing details.
When was this 8-K report filed?
This 8-K report was filed on December 8, 2025.
What is the exact name of the registrant?
The exact name of the registrant is INGEVITY CORPORATION.
What is the state of incorporation for Ingevity Corporation?
Ingevity Corporation is incorporated in Delaware.
What is the business phone number listed for Ingevity Corporation?
The business phone number listed for Ingevity Corporation is 843-740-2300.
Filing Stats: 584 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2025-12-08 06:54:59
Key Financial Figures
- $0.01 — nge on which registered Common Stock ($0.01 par value) NGVT New York Stock Exch
- $30 million — of this Current Report) completed over $30 million in stock repurchases during the fourth
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 20KB
- form8-k_001.jpg (GRAPHIC) — 11KB
- ex99-1_001.jpg (GRAPHIC) — 11KB
- 0001493152-25-026513.txt ( ) — 269KB
- ngvt-20251208.xsd (EX-101.SCH) — 3KB
- ngvt-20251208_lab.xml (EX-101.LAB) — 33KB
- ngvt-20251208_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /s/ Mary Dean Hall Mary Dean Hall Executive Vice President and Chief Financial Officer Date: December 8, 2025 3